Idose Tr
Payments companies reported to CMS as associated with Idose Tr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Idose Tr, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Idose Tr
These are the largest totals companies reported as associated with Idose Tr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Iqbal Ahmed | Salt Lake City, UT | Ophthalmology | $23,187.50 |
| Savak Teymoorian | Laguna Hills, CA | Ophthalmology | $18,705.95 |
| Inder Singh | Racine, WI | Ophthalmology | $18,028.70 |
| John Berdahl | Sioux Falls, SD | Ophthalmology | $9,445.48 |
| Leon Herndon | Durham, NC | Ophthalmology | $9,211.50 |
| Steven Sarkisian | Oklahoma City, OK | Glaucoma Specialist | $8,389.17 |
| Kerry Solomon | Mt Pleasant, SC | Ophthalmology | $6,028.70 |
| Richard Lindstrom | Bloomington, MN | Ophthalmology | $5,678.70 |
| Michael Greenwood | West Fargo, ND | Ophthalmology | $2,812.50 |
| Russell Swan | Bozeman, MT | Ophthalmology | $2,450.00 |
Prescribed Idose Tr?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.